Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 49: 1818-1821, 2003; 10.1373/clinchem.2003.019505
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krouwer, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krouwer, J. S.
Related Collections
Right arrow Laboratory Management
(Clinical Chemistry. 2003;49:1818-1821.)
© 2003 American Association for Clinical Chemistry, Inc.


Point/Counterpoint

Critique of the Guide to the Expression of Uncertainty in Measurement Method of Estimating and Reporting Uncertainty in Diagnostic Assays

Jan S. Krouwer1

1 Krouwer Consulting, 26 Parks Dr., Sherborn, MA 01770. Fax 508-647-9380; e-mail jan.krouwer{at}comcast.net.

Background: The Guide to the Expression of Uncertainty in Measurement (GUM) provides instructions for constructing uncertainty intervals for a measurement. This method is usually reserved for reference materials, but GUM has been recently proposed as a way to express uncertainty for commercial diagnostic assays.

Methods: Using the official GUM standard and published applications of GUM to commercial diagnostic assays, I undertook an analysis to evaluate whether applying GUM to commercial diagnostic assays is warranted.

Results: Certain important assays, such as troponin I, would not be candidates for GUM because troponin I is not a well-defined physical quantity. Unlike definitive methods, in which efforts are taken to detect and eliminate all systematic error sources, commercial assays often trade off features such as ease of use and cost with accuracy and allow systematic errors to be present as long as the overall accuracy meets the medical need goal. Laboratories are hindered in preparing GUM models because the knowledge required to specify some systematic errors is often available only to manufacturers. Some non-GUM methods to estimate uncertainty rely on observed data, which include both known and unknown sources of error. The occurrence of large, unknown errors for assays in routine use (e.g., outliers) is not unusual because diagnostic assays must be chemically specific in the presence of thousands of potentially interfering substances. There is no provision in GUM to deal with unexplained outliers, which may lead to uncertainty intervals that are not wide enough. Some clinicians assume that diagnostic assay results have little uncertainty. This situation may be made worse by including an uncertainty interval, which implies certification.

Conclusions: Evaluations for accuracy (total analytical error) based on describing the distribution of result differences between commercial assays and reference methods indicate that some assays have a few results with large differences (e.g., outliers). This leads to a wide accuracy interval (total analytical error limits). It is unlikely that GUM would be able to predict these wide intervals, especially because there is little or no provision for outlier treatment in GUM. Presenting too narrow GUM uncertainty intervals to clinicians would be misleading. The modeling used by practitioners of the GUM method is potentially useful in improving quality, but commercial diagnostic assays are not ready for GUM uncertainty statements.




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
M. Rynning, T. Wentzel-Larsen, and B. J. Bolann
A Model for an Uncertainty Budget for Preanalytical Variables in Clinical Chemistry Analyses
Clin. Chem., July 1, 2007; 53(7): 1343 - 1348.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
B. BERCIK INAL, M. KOLDAS, H. INAL, C. COSKUN, A. GUMUS, and Y. DOVENTAS
Evaluation of Measurement Uncertainty of Glucose in Clinical Chemistry
Ann. N.Y. Acad. Sci., April 1, 2007; 1100(1): 223 - 226.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. Middleton and J. E. Vaks
Evaluation of Assigned-Value Uncertainty for Complex Calibrator Value Assignment Processes: A Prealbumin Example
Clin. Chem., April 1, 2007; 53(4): 735 - 741.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. S. Krouwer
Uncertainty intervals based on deleting data are not useful.
Clin. Chem., June 1, 2006; 52(6): 1204 - 1205.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
R. M. Lequin
Guide to the Expression of Uncertainty of Measurement: Point/Counterpoint
Clin. Chem., May 1, 2004; 50(5): 977 - 978.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
J. Kristiansen
The Guide to Expression of Uncertainty in Measurement Approach for Estimating Uncertainty: An Appraisal
Clin. Chem., November 1, 2003; 49(11): 1822 - 1829.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.